World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
30614
World Ranking
2715
National Ranking
1293

Michael Baseler publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael Baseler sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 124 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael Baseler D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Baseler sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael Baseler is affiliated with Leidos in the United States and maintains an active research profile primarily in the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine. Their work spans several subfields including Molecular Biology, Infectious Diseases, Neurology, Virology, and Genetics.

The scientist's recent papers include studies published between 2022 and 2025 covering topics such as functional enrichment analysis, COVID-19 vaccination strategies, HIV drug resistance detection, and effects of cryopreservation on immune cell transcriptomes. The recent works are:

  • DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update), 2022, Nucleic Acids Research
  • SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial), 2025, Scientific Reports
  • HIVGenoPipe: a nextflow pipeline for the detection of HIV-1 drug resistance using a real-time sample-specific reference sequence, 2025, BMC Bioinformatics
  • The effects of cryopreservation on PBMCs transcriptome profile, 2025, Frontiers in Immunology

Michael Baseler collaborates frequently with several co-authors, among them Tomozumi Imamichi and Weizhong Chang with four joint publications each, Brad T. Sherman and H. Clifford Lane with three collaborations each, and Thomas A. Murray with two. This indicates active engagement in multidisciplinary and collaborative research environments.

The scientist's work has been published in various venues, most notably in Nucleic Acids Research, Scientific Reports, BMC Bioinformatics, and Frontiers in Immunology. These journals are associated with molecular biology, bioinformatics, infectious disease, and immunology research.

Key research topics covered by Michael Baseler include:

  • Bioinformatics and Genomic Networks
  • Gene expression and cancer classification
  • Genomics and Phylogenetic Studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • HIV Research and Treatment

This body of work reflects a focus on molecular and clinical aspects of infectious diseases such as COVID-19 and HIV, with an emphasis on genomic analysis, clinical trials, and the development of bioinformatics tools.

Best Publications

  • Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

    Tae-Wook Chun;Lieven Stuyver;Stephanie B. Mizell;Linda A. Ehler

  • HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

    Richard T. Davey;Niranjan Bhat;Christian Yoder;Tae Wook Chun

  • The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4

    SM Schnittman;MC Psallidopoulos;HC Lane;L Thompson

  • CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

    H Masur;F P Ognibene;R Yarchoan;J H Shelhamer

  • HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.

    M Connors;J A Kovacs;S Krevat;J C Gea-Banacloche

  • Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals.

    S M Schnittman;H C Lane;J Greenhouse;J S Justement

  • Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.

    Joseph A. Kovacs;Susan Vogel;Jeffrey M. Albert;Judith Falloon

  • Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

    J A Kovacs;M Baseler;R J Dewar;S Vogel

  • HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.

    Susan Moir;Angela Malaspina;Kisani M. Ogwaro;Eileen T. Donoghue

  • Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease.

    Steven M. Schnittman;Jack J. Greenhouse;Miltiades C. Psallidopoulos;Michael Baseler

  • Anti-retroviral effects of interferon-α in AIDS associated Kaposi's sarcoma

    H Clifford Lane;Judith Feinberg;Victoria Davey;Lawrence Deyton

  • Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6.

    Paolo Lusso;Andrea De Maria;Mauro Malnati;Franco Lori

  • Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

    Robert E. Walker;Christine M. Bechtel;Ven Natarajan;Michael Baseler

  • Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse.

    S K Stanley;J M McCune;H Kaneshima;J S Justement

  • Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

    H. Clifford Lane;Victoria Davey;Joseph A. Kovacs;Judith Feinberg

  • Evidence for increased T cell turnover and decreased thymic output in HIV infection.

    Daniel C. Douek;Michael R. Betts;Brenna J. Hill;Susan J. Little

  • Cellular Immune Responses to Human Papillomavirus (HPV)-16 L1 in Healthy Volunteers Immunized with Recombinant HPV-16 L1 Virus-Like Particles

    Ligia A. Pinto;Jessica Edwards;Philip E. Castle;Clayton D. Harro

  • B Cells of HIV-1–Infected Patients Bind Virions through Cd21–Complement Interactions and Transmit Infectious Virus to Activated T Cells

    Susan Moir;Angela Malaspina;Yuexia Li;Tae-Wook Chun

  • Cutting Edge: Ku70 Is a Novel Cytosolic DNA Sensor That Induces Type III Rather Than Type I IFN

    Xing Zhang;Terrence W. Brann;Ming Zhou;Jun Yang

  • Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.

    Joseph A. Kovacs;Richard A. Lempicki;Igor A. Sidorov;Joseph W. Adelsberger

Frequent Co-Authors

H. Clifford Lane
H. Clifford Lane National Institute of Allergy and Infectious Diseases
Julia A. Metcalf
Julia A. Metcalf National Institute of Allergy and Infectious Diseases
Richard T. Davey
Richard T. Davey National Institute of Allergy and Infectious Diseases
Joseph A. Kovacs
Joseph A. Kovacs National Institutes of Health
Richard A. Lempicki
Richard A. Lempicki National Institute of Allergy and Infectious Diseases
Henry Masur
Henry Masur National Institutes of Health
Michael A. Polis
Michael A. Polis National Institute of Allergy and Infectious Diseases
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Irini Sereti
Irini Sereti National Institutes of Health
Claire W. Hallahan
Claire W. Hallahan National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology opens up diverse career pathways, particularly in healthcare and research fields closely linked to advanced nursing roles. For those interested in mental health, exploring the best pmhnp programs can provide insight into top online options with excellent clinical placement rates. This ensures practical experience alongside theoretical knowledge—a critical factor for career success.

Cost is often a major consideration when pursuing further education. Fortunately, there are affordable pathways available through the cheapest psychiatric nurse practitioner programs, which balance quality and cost-effectiveness without sacrificing educational value.

Understanding potential earnings is also crucial when evaluating career options. For example, those pursuing a Doctor of Nursing Practice (DNP) role can consult data on how much does a dnp make across different states, helping to make informed decisions based on financial goals and geographic preferences.

For nurses aiming to specialize further, obtaining an acute care nurse practitioner certification offers a path to work with critically ill patients in high-demand settings. This certification is a valuable step for those transitioning from a Family Nurse Practitioner (FNP) role to acute care.

Best Scientists Citing Michael Baseler

Trending Scientists

Recently Published Articles